DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2253843/gear-up-for-interactive-brokers-ibkr-q1-earnings-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2253843 Apr 11, 2024 - Beyond analysts' top -and-bottom-line estimates for Interactive Brokers (IBKR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024. 0

https://www.zacks.com/stock/news/2253831/discover-dfs-google-cloud-team-up-to-boost-customer-service?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2253831 Apr 11, 2024 - Discover Financial (DFS) will leverage Vertex AI, Google Cloud's AI platform, to equip its around 10,000 contact center agents with gen AI-driven tools. 0

https://seekingalpha.com/news/4088853-rail-vision-gets-1-mln-order-out-of-contract-valued-at-up-to-5-mln?source=feed_tag_israel Apr 11, 2024 - Rail Vision receives initial purchase order of $1 million for its AI-based ShuntingYard products from a leading US rail and leasing services company. 0

https://www.zacks.com/stock/news/2253592/alphabet-googl-ups-generative-ai-game-with-gemini-integration?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2253592 Apr 10, 2024 - Alphabet's (GOOGL) Google integrates Gemini Pro into Android Studio's bot. It also makes Gemini 1.5 Pro available in public preview on Vertex AI. 0

https://www.fool.com/investing/2024/04/10/look-up-and-see-the-future/?source=iedfolrf0000001 Apr 10, 2024 - Sierra Space is trying to build an economy in low Earth orbit (LEO). 0

https://www.zacks.com/stock/news/2253502/moderna-mrna-up-6-on-upbeat-data-from-cancer-jab-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2253502 Apr 10, 2024 - Data from an early-stage study shows that treatment with Moderna's (MRNA) experimental cancer therapy achieved positive clinical response in patients with a specific type of head and neck cancer. 0

https://www.zacks.com/stock/news/2253351/syros-syrs-up-on-fda-fast-track-tag-for-tamibarotene-in-aml?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2253351 Apr 10, 2024 - The FDA bestows a Fast Track Designation to Syros' (SYRS) pipeline candidate, tamibarotene, in combination with venetoclax and azacitidine to treat newly diagnosed acute myeloid leukemia. Stock rises. 0

https://www.zacks.com/stock/news/2253429/nurix-nrix-up-on-upbeat-initial-data-from-phase-i-cancer-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2253429 Apr 10, 2024 - Nurix (NRIX) rises on initial findings of clinical responses in the brain for its investigational targeted protein degrader, NX-5948, which is currently under development to treat B cell malignancies. 0

https://www.fool.com/investing/2024/04/10/cathie-wood-is-loading-up-on-this-innovative-growt/?source=iedfolrf0000001 Apr 10, 2024 - Cathie Wood is a popular investment manager known for investing in high-tech companies with massive potential. 0

https://www.fool.com/investing/2024/04/10/2-dividend-stocks-to-double-up-on-right-now/?source=iedfolrf0000001 Apr 10, 2024 - These stocks have raised dividends annually for more than half a century. 0